ストーリー
2005年3月1日
GlaxoSmithKline, AstraZeneca, Merck, Pfizer & other firms join UK govt. in committing to increased access to essential medicines for poorest countries, including via differential pricing
全てのタグを見る
全てのタグを見る
Abbott Laboratories
AstraZeneca
Amgen
Bristol-Myers Squibb
Chiron
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Merck
Merck Sharp & Dohme (part of Merck)
Novartis
Pfizer
Procter & Gamble
Roche
Ranbaxy Laboratories
Schering-Plough
Shire
Tibotec (part of Johnson & Johnson)
Wyeth (part of Pfizer)
Janssen Pharmaceutica (part of Johnson & Johnson)